25 June 2019 - Deborah Wilkes
Premium
Biopharmaceutical company AbbVie is set to acquire Botox-maker Allergan in a cash and shares deal worth approximately USD63 billion.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.